Efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) in the management of malignant ascites
Abstract Objective The purpose of this study is to compare the difference of clinical efficacy between conventional intraperitoneal chemotherapy and HIPEC, so as to explore the clinical application value and advantages of HIPEC. Design A retrospective analysis was conducted on 80 patients with malig...
Main Authors: | Jie Jiao, Chengzhen Li, Guanying Yu, Lei Zhang, Xiaoyan Shi, Jingdu Yan, Houjun Zhang, Peiming Guo |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-07-01
|
Series: | World Journal of Surgical Oncology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12957-020-01956-y |
Similar Items
-
Is Palliative Laparoscopic Hyperthermic Intraperitoneal Chemotherapy Effective in Patients with Malignant Hemorrhagic Ascites
by: Louis de Mestier, et al.
Published: (2012-04-01) -
Efficacy and safety of ultrasound-guided continuous hyperthermic intraperitoneal perfusion chemotherapy for the treatment of malignant ascites: a midterm study of 36 patients
by: Wu YB, et al.
Published: (2016-01-01) -
Hyperthermic intraperitoneal chemotherapy as consolidation treatment of advanced stage ovarian cancer
by: Jieun Ko, et al.
Published: (2021-09-01) -
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) with cisplatin in pediatric patients with peritoneal mesothelioma: a single institution experience and long term follow up
by: Parisa Malekzadeh, et al.
Published: (2021-01-01) -
Is cytoreductive surgery and hyperthermic intraperitoneal chemotherapy indicated in hepatobiliary malignancies?
by: Natasha Leigh, et al.
Published: (2020-06-01)